Wayne Ray’s 50-year career helped transform pharmacoepidemiology research

To celebrate Ray’s career and contributions to research and education at VUMC, the Department of Health Policy will host a symposium from 9 a.m.-1 p.m. on Monday, Dec. 9 in Light Hall 202.

Common AFib drug linked to higher bleeding risk 

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.

Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications

High-dose antipsychotics place children at increased risk of unexpected death

Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according to a Vanderbilt University Medical Center study published today in JAMA Psychiatry.
Unexpected death includes deaths due to unintentional drug overdose or cardiovascular/metabolic causes.

Study defines association of oral anticoagulants and proton pump inhibitors to gastrointestinal bleeding risk

A Vanderbilt University Medical Center study published this week in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant.

VUSM’s MPH Program celebrates 20th anniversary

The Vanderbilt University School of Medicine Master of Public Health (MPH) Program marked its 20th anniversary during Reunion Weekend in October.